| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Curanex Pharmaceuticals Inc | CEO and President, Director, 10%+ Owner | Common Stock | 7,076,160 | 25 Aug 2025 | Direct | ||
| Curanex Pharmaceuticals Inc | CEO and President, Director, 10%+ Owner | Common Stock | 912,600 | 25 Aug 2025 | Indirect | ||
| Curanex Pharmaceuticals Inc | CEO and President, Director, 10%+ Owner | Series A Preferred Stock | 490,000 | 25 Aug 2025 | Direct | ||
| Curanex Pharmaceuticals Inc | CEO and President, Director, 10%+ Owner | Series A Preferred Stock | 200,000 | 25 Aug 2025 | Indirect |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000164117225026283-liu-jun-2025-08-25 | Curanex Pharmaceuticals Inc | 25 Aug 2025 | 0 | $0 | 3 | CEO and President, Director, 10%+ Owner | 02 Sep 2025, 20:30 |